TickerFactsScreenerDevelopers

Allogene Therapeutics, Inc. (ALLO) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2018: -$44.65M2019: -$137.35M2020: -$115.09M2021: -$184.81M2022: -$220.52M2023: -$237.73M2024: -$200.30M2025: -$149.25M-$149.25M
2018Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$149.25M+25.5%
2024-$200.30M+15.7%
2023-$237.73M-7.8%
2022-$220.52M-19.3%
2021-$184.81M-60.6%
2020-$115.09M+16.2%
2019-$137.35M-207.6%
2018-$44.65M—